![]() Circulating tumor DNA (ctDNA) is a promising tool to use as a non-invasive biomarker for cancer mutation profiling. However, acquisition of representative tumor samples is invasive and sometimes impossible. is a disease of complex genetic alterations, and comprehensive genetic diagnosis is beneficial to match each patient to appropriate therapy. 9 Geneseeq Technology Inc., Toronto, Ontario, Canada. ![]() 8 Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu, Sichuan, China.7 Department of Medical Oncology, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangzhou, China.6 Department of Chemoradiotherapy, Yinzhou Hospital Affiliated to Medical School of Ningbo University, Ningbo, Zhejiang, China.5 Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Jiangsu Cancer Hospital, Nanjing, Jiangsu, China.4 Department of Medical Oncology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.3 Nanjing Geneseeq Technology Inc., Nanjing, Jiangsu, China.2 Geneseeq Technology Inc., Toronto, Ontario, Canada.1 Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |